ApprovalTrail

Drug · DIN 02014327

MS CONTIN

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since December 31, 1993; first marketed December 31, 1993.
Drug Identification Number (DIN)
02014327
Company (DIN owner)
Purdue PharmaToronto, Ontario, Canada
Schedule
Narcotics (cdsa i)
Dosage form
Tablet (Extended-Release)
Route
Oral
Therapeutic class (ATC)
Morphine N02AA01
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
MORPHINE SULFATE200 MG

Other DINs named MS CONTIN